{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:45:37Z","timestamp":1790358337826,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T00:00:00Z","timestamp":1390262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085935","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T22:05:35Z","timestamp":1390341935000},"page":"e85935","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma"],"prefix":"10.1371","volume":"9","author":[{"given":"Ombretta","family":"Melaiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Stebbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylenia","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihisa","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bonotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Cristaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Foddis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Mutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Barale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Gemignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Giamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0021-9258(17)42180-6","article-title":"A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5.","volume":"269(2)","author":"N Yamaguchi","year":"1994","journal-title":"J Biol Chem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.","volume":"93(1)","author":"K Chang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy.","volume":"1)","author":"R Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy.","volume":"44(1)","author":"R Hassan","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref5","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).","volume":"7(12)","author":"P Argani","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"K Chang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1349-7006.2007.00715.x","article-title":"Aberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cells.","volume":"99(3)","author":"C Sapede","year":"2008","journal-title":"Cancer Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"BW Robinson","year":"2003","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1078-0432.CCR-05-1477","article-title":"Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer","volume":"12","author":"R Hassan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","article-title":"Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment","volume":"13","author":"BD Grigoriu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/MCB.20.8.2902-2906.2000","article-title":"Mesothelin is not required for normal mouse development or reproduction.","volume":"20(8)","author":"TK Bera","year":"2000","journal-title":"Mol Cell Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"A Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/srep01870","article-title":"Mesothelin binding to CA125\/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation","volume":"3","author":"SH Chen","year":"2013","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1158\/1541-7786.MCR-08-0095","article-title":"Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3","volume":"6","author":"U Bharadwaj","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/1871520611313020014","article-title":"The role of mesothelin in tumor progression and targeted therapy.","volume":"13(2)","author":"Z Tang","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00002371-200007000-00011","article-title":"Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma.","volume":"23(4)","author":"R Hassan","year":"2000","journal-title":"J Immunother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.vaccine.2006.06.087","article-title":"A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors.","volume":"25(1)","author":"CF Hung","year":"2007","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.gt.3302913","article-title":"Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells.","volume":"14(12)","author":"CF Hung","year":"2007","journal-title":"Gene Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.gt.3302404","article-title":"Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy.","volume":"12(2)","author":"M Breidenbach","year":"2005","journal-title":"Gene Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7150\/jca.1.141","article-title":"Mesothelin as a potential therapeutic target in human cholangiocarcinoma.","volume":"1","author":"L Yu","year":"2010","journal-title":"J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1535-7163.MCT-12-0731","article-title":"A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface.","volume":"12(4)","author":"Z Tang","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref22","first-page":"20","article-title":"Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.","volume":"7","author":"R Hassan","year":"2007","journal-title":"Cancer Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.canlet.2008.04.002","article-title":"siRNA-mediated Erc gene silencing suppresses tumor growth in Tsc2 mutant renal carcinoma model.","volume":"268(2)","author":"O Imamura","year":"2008","journal-title":"Cancer Lett"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1756-9966-31-84","article-title":"Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.","volume":"31","author":"C Zheng","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e33214","DOI":"10.1371\/journal.pone.0033214","article-title":"Inhibition of mesothelin as a novel strategy for targeting cancer cells","volume":"7(4)","author":"K Wang","year":"2012","journal-title":"PLOS ONE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-4608(89)90014-9","article-title":"Characterization of three human malignant mesothelioma cell lines","volume":"42(1)","author":"MA Versnel","year":"1989","journal-title":"Cancer Genet Cytogenet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.99.13352799","article-title":"Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis","volume":"13(3)","author":"AM Orengo","year":"1999","journal-title":"Eur Respir J"},{"key":"ref28","first-page":"RESEARCH0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3(7)","author":"J Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"V Vichai","year":"2006","journal-title":"Nat Protoc"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1517\/14728222.2011.639361","article-title":"The RAS\/RAF\/MEK\/ERK and the PI3K\/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches","volume":"16","author":"A De Luca","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"CC Liang","year":"2007","journal-title":"Nat Protoc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-61779-207-6_8","article-title":"Transwell(\u00ae) invasion assays","volume":"769","author":"J Marshall","year":"2011","journal-title":"Methods Mol Biol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0180317","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T07:06:24Z","timestamp":1648105584000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085935"}},"subtitle":[],"editor":[{"given":"Mitchell","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,21]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085935","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,21]]}}}